When asked about new sequencing technologies under development that could outdo Illumina's machines, Mr. O'Day said those were still in "an early feasibility stage" and were unproven.
This revolution involves new sequencing technologies, bioinformatics pipelines, computational infrastructure, and experimental designs.
The advent of disruptive new sequencing technologies brought about an unprecedented acceleration in our learning curve.
Nevertheless, the huge amount of genomic data produced by the new sequencing technologies prevents this practice.
New sequencing technologies pose significant challenges in terms of data complexity and magnitude.
New sequencing technologies are also known as next-generation sequencing (NGS), which makes reference to the first generation of Sanger sequencing technology.
More recently, new sequencing technologies have allowed the identification of driver mutations in epigenetic regulators, providing a mechanistic link between the cancer epigenome and genetic alterations.
New sequencing technologies are generating so much data, he says, that automation is becoming essential, so suitable coding skills are becoming indispensable.
In recent years, Siegel has left Applied Biosystems to help Illumina and later Complete Genomics put new sequencing technologies onto the market.
This would be achieved by increasing the number of groups working on large-scale sequencing and heightening efforts to develop new sequencing technologies.
Today, new sequencing technologies have brought the figure close to $1000 per genome, although precise costs are hard to come by.
